Phase 1 | Phase 2 | P-value | ||
---|---|---|---|---|
Number of patients with risk factors (%) | ||||
Previous colonization/infection | 12 (0.05) | 111 (0.4) | ||
Previous admission to HCFs within 6 months | 6,662 (30.0) | 8,889 (32.6) | < 0.001 | |
Receipt of hemodialysis | 620 (2.8) | 798 (2.9) | < 0.001 | |
Transfer from outside HCFs | 1406 (6.3) | 2111 (7.7) | < 0.001 | |
Number of ICU patients eligible for screening (%) | ||||
ICU universal admission screening | 2,376 (10.7) | 2,652 (9.7) | < 0.001 | |
ICU weekly screening | NA | 765 (2.8) | ||
Positive screening per 1,000 screens1 | IRR (95% CI) | P-value | ||
Admission screening | 11.7 | 5.3 | 0.45 (0.29–0.71) | 0.001 |
ICU universal admission screening | 9.4 | 4.4 | 0.47 (0.19–1.14) | 0.07 |
ICU weekly screening | 18.8 | |||
Positive screening per 1,000 admissions1 | IRR (95% CI) | P-value | ||
Admission screening | 1.2 | 2.3 | 1.90 (1.21–2.99) | 0.005 |
ICU universal admission screening | 5.5 | 4.2 | 0.76 (0.31–1.83) | 0.507 |
ICU weekly screening | 15.7 | |||
Incidence of CPE colonization/infection per 1,000 admissions | IRR (95% CI) | P-value | ||
Total new CPE patients | 3.1 | 3.4 | 1.08 (0.79–1.48) | 0.613 |
New CPE from screening samples | 2.6 | 3.3 | 1.27 (0.91–1.76) | 0.162 |
New CPE from clinical samples | 0.5 | 0.1 | 0.20 (0.06–0.72) | 0.014 |
Hospital-onset CPE patients | 1.9 | 1.1 | 0.57 (0.36–0.91) | 0.018 |
Patients with CPE-positive clinical cultures1 | 0.7 | 0.4 | 0.65 (0.31–1.39) | 0.270 |